Michael Schoppet

Increased Osteoprotegerin Serum Levels in Men with Coronary Artery Disease

Michael Schoppet, Alexander Sattler, Juergen R. Schaefer et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 319 citations

Hypertension, Vascular Disease, Opg Serum Levels +17

Human Decidua Contains Potent Immunostimulatory CD83+ Dendritic Cells

Ulrike Kämmerer, Michael Schoppet, Alexander D. McLellan et al. · American Journal Of Pathology · 2000 · 197 citations · Full text

Immunology, Autoimmunity, Immunomodulation +5

Localization of Osteoprotegerin, Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand, and Receptor Activator of Nuclear Factor-κB Ligand in Monckeberg’s Sclerosis and Atherosclerosis

Michael Schoppet, Nadia Al‐Fakhri, Folker E. Franke et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 181 citations

The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis

Rukshana Shroff, V Shah, Melanie P. Hiorns et al. · Nephrology Dialysis Transplantation · 2008 · 172 citations

Inhibition of Receptor Activator of NF-κB Ligand by Denosumab Attenuates Vascular Calcium Deposition in Mice

Susann Helas, Claudia Goettsch, Michael Schoppet et al. · American Journal Of Pathology · 2009 · 154 citations · Full text

Inflammation, Molecular Pharmacology, Nf-κb Ligand +11